Pancreatic Cancer Research

ResearcherRoyal Marsden NHS Foundation TrustNo recent work listed

Satvinder Mudan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9439-5354; OpenAlex author ID A5073405977. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 3 papers · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 2 papers

Papers 11

  1. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer. Co-author DOI 10.1038/s41598-019-57287-w↗
  2. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the id… Co-author DOI 10.3892/or.2020.7822↗
  3. Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic d… Last author DOI 10.14701/ahbps.2018.22.3.197↗
  4. Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.25017↗
  5. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Co-author DOI 10.1038/s41419-017-0001-z↗
  6. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. Last author DOI 10.1038/bjc.2016.271↗
  7. Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer? Co-author DOI 10.1080/2162402x.2015.1112942↗
  8. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectom… Last author DOI 10.1002/jso.23867↗
  9. Long-term Disease-free Survival Following Combination Multi-visceral and Metastatic Resection with Neoadjuvant FOLFIRINOX for Pancreatic Adenocarcinoma: A Case… Last author DOI 10.7759/cureus.429↗
  10. Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and … Last author DOI 10.7759/cureus.435↗
  11. Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis. Co-author DOI 10.1111/boc.201300021↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Angus George Dalgleish · 4 shared papers, 2016–2020 · strength 0.40
  2. Helmout Modjtahedi · 3 shared papers, 2018–2020 · strength 0.36
  3. Gustavo A. Arias-Pinilla · 2 shared papers, 2018–2020 · strength 0.23
  4. David Cunningham · 3 shared papers, 2015–2018 · strength 0.23
  5. Mafalda Costa Neves · 2 shared papers, 2015–2018 · strength 0.16
  6. Alexandros E. Giakoustidis · 2 shared papers, 2015–2018 · strength 0.16
  7. Kyriakos Neofytou · 2 shared papers, 2015–2018 · strength 0.16
  8. Tanzeel Khan · 1 shared paper, 2020 · strength 0.13
  9. Nikolaos Ioannou · 1 shared paper, 2020 · strength 0.13
  10. Androulla Elia · 2 shared papers, 2013–2017 · strength 0.11
  11. Dimitrios E. Giakoustidis · 1 shared paper, 2018 · strength 0.09
  12. Laura Rosa Brunet · 1 shared paper, 2016 · strength 0.08
  13. Aurélien Marabelle · 1 shared paper, 2016 · strength 0.08
  14. Thorsten Hagemann · 1 shared paper, 2016 · strength 0.08
  15. Stéphane Pyronnet · 1 shared paper, 2017 · strength 0.07
  16. Mikael Hans Sodergren · 1 shared paper, 2015 · strength 0.07
  17. Andrés Jesús Muñoz Martín · 1 shared paper, 2016 · strength 0.04
  18. Justin Stebbing · 1 shared paper, 2016 · strength 0.04
  19. Demetris Papamichael · 1 shared paper, 2016 · strength 0.04
  20. Douglas J.A. Adamson · 1 shared paper, 2016 · strength 0.04
  21. Ray McDermott · 1 shared paper, 2016 · strength 0.04
  22. Robert Díaz Beveridge · 1 shared paper, 2016 · strength 0.04
  23. Roberto Pazo-Cid · 1 shared paper, 2016 · strength 0.04
  24. David Kuang-Fu Chang · 1 shared paper, 2016 · strength 0.04
  25. Alberto Zaniboni · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.